JPRN-jRCT2080225352CompletedPhase 2
Randomized, Double-Blind Study of AK1830 in Patients with low back pain
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to <= 85age old (—)
- Sex
- All
Inclusion Criteria
- •Patient with low back pain
Exclusion Criteria
- •*Patient has renal, hepatic, cardiac, pancreatic, or metabolic diseases or hematologic abnormality.
- •*Patients with a history or complication of malignancy within 5 years
- •*Patient who are pregnant or may be pregnant, who wants to be pregnant during the trial period, patients who are nursing. Patient who cannot agree on proper contraception in the patient or the patient's female partner is a pregnant woman
Investigators
Similar Trials
Completed
Phase 2
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.JPRN-jRCT2080224985Asahi Kasei Pharma Corporation400
Not yet recruiting
Phase 2
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.Pain due to osteoarthritisJPRN-jRCT2031230469Kudo Katsuyasu400
Completed
Phase 2
Follow ups of patients in AK1830 Phase II Studiesosteoarthritis, chronic lumbar painJPRN-jRCT2031210566Kudo Katsuyasu10
Completed
Phase 1
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200119Shimizu Tomohito20
Completed
Phase 1
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200123Shimizu Tomohito40